Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy

• Status: Not yet recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to investigate the efficacy and safety of bromfenac sodium hydrate eye drops in patients with familial exudative vitreoretinopathy receiving diode laser photocoagulation.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Bromfenac

Criteria

Inclusion Criteria:

• Newly diagnosed patients with familial exudative vitreoretinopathy

• Needing diode laser photocoagulation

• Consent to the study

Exclusion Criteria:

• History of corneal diseases

• History of hypersensitivity to bromfenac sodium

• History of hypersensitivity to non-steroidal anti-inflammatory drugs

• Progressive ocular infection

• Liver diseases

• Hypersensitivity to sulfur dioxide

• Receiving anti-coagulation drugs

• History of coagulopathies